Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 57
- 试验地点
- 2
- 主要终点
- Adherence to diet protocols
研究概览
简要总结
To test whether a lifestyle program featuring one of two forms of intermittent fasting (IER or TRE) can feasibly and effectively improve glycemia in patients with type 2 diabetes, and potentially induce diabetes remission.
详细描述
Intermittent energy restriction (IER) and time-restricted eating (TRE) are two distinct forms of intermittent fasting which have yet to be compared for the treatment of type 2 diabetes. Investigators will test whether a comprehensive, intensive lifestyle program featuring each of these intermittent fasting approaches is feasible and effective for improving glycemic control in patients diagnosed with type 2 diabetes within the past 10 years. Both interventions will be delivered over one year in three phases: (1) a 12-week weight loss program featuring weekly group meetings, (2) a 12-week weight maintenance program featuring biweekly group meetings, and (3) a 6-month low-contact follow up period featuring monthly check-ins.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 21 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with type 2 diabetes in the past 10 years.
- •Age 21-65 years
- •BMI of 25 - 45 kg/m2
- •HbA1c of 6.7-9.5%, or those with A1c of <6.7% on glucose-lowering medications
- •Ability to participate in a graduated physical activity program
- •Clearance from study physician.
排除标准
- •Inability to attend health education meetings.
- •Weight change of >=5% in the previous 3 months.
- •Addition of new antihyperglycemic or weight-reducing medication in the previous 2 months.
- •Serious medical risk such as ongoing treatment for cancer, uncontrolled hypertension, recent cardiac event, or other medical condition presenting acute risk of participation in a lifestyle change program.
- •Untreated depression or anxiety, or increase in associated medications in the previous 3 months.
- •Current participation in another lifestyle change intervention, such as a tobacco cessation program or physical activity program.
- •Pregnancy or lactation within the previous six months
- •Weight of >450 lbs
- •Currently taking medications that may result in hypoglycemia during fasting and unwilling to stop prior to the study
结局指标
主要结局
Adherence to diet protocols
时间窗: Weekly from baseline to 52 weeks
Acceptability of IER and TRE over one year as assessed by compliance to program recommendations (# weeks adhered / # study weeks).
Retention
时间窗: 52 weeks
Feasibility of IER and TRE over one year assessed by retention (# completed / # enrolled) and attendance (# classes attended / # classes offered).
次要结局
- HbA1c(Change from baseline to 24 weeks)
- Insulin sensitivity(Change from baseline to 24 weeks)
- Oral Glucose Tolerance Test(Change from baseline to 24 weeks)
- Isulin resistance(Change from baseline to 24 weeks)
研究者
Felicia Steger
Assistant Professor
University of Kansas Medical Center